Exactech Mass Tort Case Leads
Connect with patients who required revision surgery after receiving recalled Exactech joint replacement components.
Exactech Knee, Hip, and Ankle Implant Recall Litigation
Exactech issued a series of recalls between 2021 and 2022 covering its Optetrak, Optetrak Logic, and Truliant knee systems, Vantage ankle implants, and Connexion GXL hip liners. The recalls centered on defective vacuum-sealed packaging that allowed oxygen to degrade the polyethylene inserts before implantation, causing accelerated wear, bone loss, and early device failure — often years ahead of a joint replacement's expected lifespan. Federal claims are consolidated in MDL 3044 before Judge Nicholas G. Garaufis in the Eastern District of New York, with 1,838 cases pending as of July 2026. Firms should note the docket's posture: Exactech filed for Chapter 11 bankruptcy protection in late 2024, which triggered an automatic stay pausing the MDL and vacating a bellwether trial schedule that had been set for 2025. The court is receiving periodic status reports while the reorganization proceeds, and recovery timing and ceiling for claimants now depend substantially on the bankruptcy outcome.
Associated Conditions
- Revision surgery to replace a failed knee, hip, or ankle implant
- Accelerated polyethylene wear and component loosening
- Osteolysis (bone loss) around the implant
- Persistent pain, swelling, or instability in the joint
- Grinding, clicking, or inability to bear weight
- Implant failure well before the expected device lifespan
- Infection or fracture associated with device failure
Claimant Eligibility
- Received an Exactech Optetrak, Optetrak Logic, Truliant, Vantage, or Connexion GXL component
- Implant falls within a recalled lot or date range (recalls issued 2021–2022)
- Underwent revision surgery, or has been advised revision is required
- Operative reports and implant records identifying the Exactech device
- Claim filed within the applicable state statute of limitations
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Exactech legal marketing campaigns: how we acquire cases
Exactech case acquisition runs as a multi-channel program, not a single ad buy. Product liability and class action claimants research their condition long before they contact a lawyer, so we meet potential clients at each stage — paid demand capture for people already searching, paid social and traditional media for people who have not yet connected their injury to the litigation, and organic search for the long research tail.
Digital marketing channels
- Google Ads and paid search demand capture
- Meta and paid social prospecting by exposure profile
- Mass tort search engine optimization for the research tail
- OTT and connected TV retargeting
Traditional media channels
- Broadcast and cable TV in qualifying DMAs
- Radio and streaming audio
- Direct response print in occupational verticals
- Earned media and litigation PR support
How the channel mix is built, budgeted, and measured is covered in our mass tort marketing guide. For intake handling once the lead lands, see mass tort intake.
Running a Exactech mass tort marketing campaign
Common questions from law firms about Exactech lawsuit lead generation and campaign management.
- What does a Exactech mass tort marketing campaign include?
- A Exactech mass tort marketing campaign from Mass Tort Marketing Agency covers multi-channel strategy across Meta, Google PPC, OTT and connected TV, traditional media, and mass tort search engine optimization; compliant ad creative; TCPA-verified intake; claimant qualification against your Exactech case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
- How do you generate Exactech mass tort case leads?
- Exactech mass tort case leads are generated through paid social and search campaigns aimed at the specific exposure and injury profile of the litigation, supported by organic content that captures claimants already researching their condition. Every lead is a real, consented claimant — we do not buy aggregated lists or resell shared data.
- What do Exactech legal marketing campaigns cost?
- Exactech legal marketing campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. Cost per retainer varies by tort based on claimant prevalence, media competition, and how tight your case criteria are. We scope a per-tort figure before any spend commitment.
- Are Exactech leads exclusive to my firm?
- Yes. Every Exactech lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are Exactech claimants qualified before delivery?
- Each Exactech claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a certified TrustedForm or Jornaya consent record — preserving the exact disclosure language shown at submission — before the lead reaches your intake team.
- How fast can a Exactech case acquisition program scale?
- A Exactech mass tort case acquisition program typically moves from scoping to live media inside two weeks, with volume ramped against your docket capacity rather than pushed to a fixed budget. Volume can be scaled up or down by tort month to month as the litigation posture changes.
- How does the Exactech bankruptcy affect running a campaign on this tort?
- It materially changes the economics, and firms should size spend accordingly. The Chapter 11 filing stayed MDL 3044, so cases are not progressing toward trial on the schedule that existed before, and claimant recovery will be shaped by the reorganization and any resulting claims process rather than by MDL bellwether values. Firms typically treat Exactech as a longer-horizon docket-building play rather than a near-term settlement play. We will build and run the campaign either way, but we flag the posture before you commit budget rather than after.
- Do Exactech campaigns screen for revision surgery specifically?
- Yes. Revision surgery — or a documented surgical recommendation for one — is the primary value driver on this tort, so intake verifies the implant type and recall lot, the implanting and revising facilities, surgery dates, and the operative reports before a claimant is delivered. Claimants with a recalled implant but no failure and no revision are flagged separately rather than delivered as qualified files. Your firm makes the final eligibility determination.
Get Exactech campaign pricing on a 30-minute call
We will walk your Exactech case criteria, current cost per signed retainer, and the volume your docket can absorb — and tell you plainly if this tort is not a fit right now.
See how every lead is qualified on our mass tort leads page, read the full mass tort marketing guide, or compare providers in our top mass tort marketing firms guide.